Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 611, Issue 1-2, 2006, Pages 71-82

  Steffensen, Inger Lise ^a   Schut, Herman A J ^b   Nesland, Jahn M ^c   Tanaka, Kiyoji ^d   Alexander, Jan ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c UNIVERSITY OF OSLO   (Norway)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

DNA adducts; Intestinal tumorigenesis; Min mouse; Nucleotide excision repair; PhIP; Xeroderma pigmentosum group A; Xpa mouse

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; APC PROTEIN; PROTEIN; PROTEIN XPA; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; EXCISION REPAIR; FEMALE; GENOTYPE; HOMOZYGOSITY; INTESTINE TUMOR; LIFESPAN; MALE; MOUSE; MULTIPLE CANCER; NONHUMAN; PRIORITY JOURNAL; PROGENY; SMALL INTESTINE; TUMOR LOCALIZATION; XERODERMA PIGMENTOSUM;

ANIMALS; BODY WEIGHT; COLON; DNA ADDUCTS; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMIDAZOLES; INTESTINAL NEOPLASMS; INTESTINES; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; SURVIVAL ANALYSIS; SURVIVAL RATE; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

XERODERMA PIGMENTOSUM;

EID: 33751165069     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2006.07.004     Document Type: Article

References (38)

1. Schut H.A.J., and Snyderwine E.G. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis 20 (1999) 353-368
2. Steffensen I.-L., Paulsen J.E., Eide T.J., and Alexander J. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice. Carcinogenesis 18 (1997) 1049-1054
3. Paulsen J.E., Steffensen I.-L., Andreassen A., Vikse R., and Alexander J. Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice. Carcinogenesis 20 (1999) 1277-1282
4. Steffensen I.-L., Schut H.A.J., Paulsen J.E., Andreassen A., and Alexander J. Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts. Cancer Res. 61 (2001) 8689-8696
5. + allele. Mutagenesis 16 (2001) 309-315
6. Andreassen A., Møllersen L., Vikse R., Steffensen I.-L., Mikalsen A., Paulsen J.E., and Alexander J. One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Apc gene. Mutat. Res. 517 (2002) 157-166
7. Møllersen L., Vikse R., Andreassen A., Steffensen I.-L., Mikalsen A., Paulsen J.E., and Alexander J. Adenomatous polyposis coli truncation mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumours of multiple intestinal neoplasia mice. Mutat. Res. 557 (2004) 29-40
8. Turesky R.J. Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis. Drug Metab. Rev. 34 (2002) 625-650
9. Turesky R.J. The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines. Curr. Drug Metab. 5 (2004) 169-180
10. Steffensen I.-L., Schut H.A.J., and Alexander J. Age at exposure and Apc status influence the levels of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in mouse intestine and liver. Mutat. Res. 587 (2005) 73-89
11. de Boer J., and Hoeijmakers J.H.J. Nucleotide excision repair and human syndromes. Carcinogenesis 21 (2000) 453-460
12. Nakane H., Takeuchi S., Yuba S., Saijo M., Nakatsu Y., Murai H., Nakatsuru Y., Ishikawa T., Hirota S., Kitamura Y., Kato Y., Tsunoda Y., Miyauchi H., Horio T., Tokunaga T., Matsunaga T., Nikaido O., Nishimune Y., Okada Y., and Tanaka K. High incidence of ultraviolet-B- or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature 377 (1995) 165-168
13. de Vries A., van Oostrom C.T.M., Hofhuis F.M.A., Dortant P.M., Berg R.J.W., de Gruijl F.R., Wester P.W., van Kreijl C.F., Capel P.J.A., van Steeg H., and Verbeek S.J. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 377 (1995) 169-173
14. Moser A.R., Shoemaker A.R., Connelly C.S., Clipson L., Gould K.A., Luongo C., Dove W.F., Siggers P.H., and Gardner R.L. Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Dev. Dynam. 203 (1995) 422-433
15. Moser A.R., Pitot H.C., and Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247 (1990) 322-324
16. Schut H.A.J., and Herzog C.R. Formation of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in male Fischer-344 rats. Cancer Lett. 67 (1992) 117-124
17. Cummings D.A., and Schut H.A.J. Removal of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the male Fischer-344 rat. Carcinogenesis 15 (1994) 2623-2628
18. Imaida K., Ogawa K., Takahashi S., Ito T., Yamaguchi T., Totsuka Y., Wakabayashi K., Tanaka K., Ito N., and Shirai T. Delay of DNA-adduct repair and severe toxicity in xeroderma pigmentosum group A gene (XPA) deficient mice treated with 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP). Cancer Lett. 150 (2000) 63-69
19. -/- mice. Carcinogenesis 22 (2001) 619-626
20. 1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res. 80 (1989) 1176-1178
21. Endo H., Schut H.A.J., and Snyderwine E.G. Mutagenic specificity of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the supF shuttle vector system. Cancer Res. 54 (1994) 3745-3751
22. Shoemaker A.R., Moser A.R., and Dove W.F. N-Ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts. Cancer Res. 55 (1995) 4479-4485
23. Jagelman D.G. Extracolonic manifestations of familial polyposis coli. Semin. Surg. Oncol. 3 (1987) 88-91
24. Steffensen I.-L., Schut H.A.J., Tanaka K., and Alexander J. Increased 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced and spontaneous intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice crossed with xeroderma pigmentosum group A (Xpa) deficient mice. Proc. Am. Assoc. Cancer Res. 45 (2004) 360
25. Damia G., Guidi G., and D'Incalci M. Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines. Eur. J. Cancer 34 (1998) 1783-1788
26. Muotri A.R., Marchetto M.C.N., Suzuki M.F., Okazaki K., Lotfi C.F.P., Brumatti G., Amarante-Mendes G.P., and Menck C.F.M. Low amounts of the DNA repair XPA protein are sufficient to recover UV-resistance. Carcinogenesis 23 (2002) 1039-1046
27. Hoeijmakers J.H.J., Eker A.P.M., Wood R.D., and Robins P. Use of in vivo and in vitro assays for the characterization of mammalian excision repair and isolation of repair proteins. Mutat. Res. 236 (1990) 223-238
28. Venema J., van Hoffen A., Natarajan A.T., van Zeeland A.A., and Mullenders L.H.F. The residual repair capacity of xeroderma pigmentosum complementation group C fibroblasts is highly specific for transcriptionally active DNA. Nucleic Acids Res. 18 (1990) 443-448
29. Venema J., Mullenders L.H.F., Natarajan A.T., van Zeeland A.A., and Mayne L.V. The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc. Natl. Acad. Sci. USA 87 (1990) 4707-4711
30. Olsen A.-K., Duale N.M., Andreassen A., Hongslo J., Vikse R., Steffensen I.-L., Alexander J., and Brunborg G. Involvement of the adenomatous polyposis coli (Apc) gene in repair of PhIP-DNA adducts via nucleotide excision repair (NER). 32nd Annual Meeting of the European Environmental Mutagen Society (EEMS). Warsaw, Poland, September 3-7 (2002)
31. Fearnhead N.S., Britton M.P., and Bodmer W.F. The ABC of APC. Hum. Mol. Genet. 10 (2001) 721-733
32. van Es J.H., Giles R.H., and Clevers H.C. The many faces of the tumor suppressor gene APC. Exp. Cell Res. 264 (2001) 126-134
33. Lustig B., and Behrens J. The Wnt signaling pathway and its role in tumor development. J. Cancer Res. Clin. Oncol. 129 (2003) 199-221
34. Doucas H., Garcea G., Neal C.P., Manson M.M., and Berry D.P. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur. J. Cancer 41 (2005) 365-379
35. Sansom O.J., Reed K.R., Hayes A.J., Ireland H., Brinkmann H., Newton I.P., Batlle E., Simon-Assmann P., Clevers H., Nathke I.S., Clarke A.R., and Winton D.J. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 18 (2004) 1385-1390
36. Neufeld K.L., Nix D.A., Bogerd H., Kang Y., Beckerle M.C., Cullen B.R., and White R.L. Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc. Natl. Acad. Sci. USA 97 (2000) 12085-12090
37. Zhang F., White R.L., and Neufeld K.L. Phosphorylation near nuclear localization signal regulates nuclear import of adenomatous polyposis coli protein. Proc. Natl. Acad. Sci. USA 97 (2000) 12577-12582
38. Deka J., Herter P., Sprenger-Haußels M., Koosch S., Franz D., Müller K.-M., Kuhnen C., Hoffmann I., and Müller O. The APC protein binds to A/T rich DNA sequences. Oncogene 18 (1999) 5654-5661